Burkitt's lymphomas (BL) are characterized by the constitutive expression of c-Myc protein. In total, 50-60% of all BL cells carry mutant c-Myc proteins. Using a mouse model of spontaneously immortalized pro-Blymphocytes (Ba/F3), we have investigated genomic instability mediated by the conditional expression of either wild-type (WT) or deletion box II D106-Myc proteins. We found that both proteins mediate common as well as differing types of chromosomal rearrangements as documented by spectral karyotyping (SKY). A higher level of genomic instability is induced by the D106-Myc protein. To examine the tumorigenic potential of WT or D106-driven Ba/F3 cells, in vivo tumorigenesis studies were performed in SCID mice. Under the experimental conditions of this study, WT but not D106-Myc expressing Ba/F3 cells triggered tumorigenesis in SCID mice. Therefore, the genomic instability phenotype induced by D106-Myc can be genetically uncoupled from its tumorigenic potential.
Introduction
The proto-oncogene c-myc plays an important role in transformation being overexpressed in many tumors (for a review, see Nesbit et al., 1999) . One pathway through which Myc contributes to cellular transformation is the generation of genomic instability (Mai and Mushinski, 2003) . A classical example of c-Myc-dependent tumorigenesis is the human Burkitt's lymphoma (BL). In BL, c-myc is translocated to one of the immunoglobulin (Ig) loci and constitutively activated due to the Ig enhancers that control its expression (Klein, 1986) . The presence of point mutations in Myc proteins in about 60% of all BL is one remarkable aspect about this tumor (Bhatia et al., 1993) . The mutations fall into two main categories, those located in the myc box I (amino acid 47-62) or in the myc box II (amino acids 106-143). The precise role of these Myc mutants in the B cell transformation to BL is still enigmatic.
Previous studies have commonly used fibroblasts to examine the role of BL-derived mutant Myc proteins (both myc box I and myc box II). In this cellular context, Myc box I mutations generally affected c-Myc-mediated transactivation (Amin et al., 1993; Li et al., 1994; Lee et al., 1997; Marhin et al., 1997; Oster et al., 2003) . In contrast, Myc box II was required for transcriptional repression, transformation and cell cycle progression (Stone et al., 1987; Goruppi et al., 1994; Li et al., 1994; Lee et al., 1997) and for apoptosis (Kuttler et al., 2001) .
Using a lymphocyte model consisting of spontaneously immortalized mouse Ba/F3 pro-B lymphocytes, we have previously examined the conditional expression of wildtype (WT) and mutant Myc proteins (B13, B16) and a deletion of myc box II (D106) in a B cell lineage-specific manner (Fest et al., 2002) . Our data showed in Ba/F3 cells that mutant Myc proteins induced lower levels of apoptosis than their WT counterparts (Fest et al., 2002) . The same study demonstrated that both WT and mutant Myc proteins are capable of inducing locus-specific genomic instability as well as chromosomal instability. However, mutant and deletion Myc box II proteins frequently induced polyploidization that was not observed in WT Myc-induced Ba/F3 cells (Fest et al., 2002) .
The present study was undertaken to define the structural genomic instability induced by the conditional expression of deletion box II (D106) or WT Myc protein in this mouse lymphocyte model and to test the relevance of WT or D106-Myc-induced genomic instability for tumorigenesis in vivo, using SCID mice.
Results

Induction of functional MYC expression and detection of c-Myc proteins
The three cell lines, parental Ba/F3, WT and D106 used in our study were previously characterized by Western blotting (Fest et al., 2002) . In order to analyse genetic abnormalities induced after c-Myc activation, the efficacy of the experimentally conditional pBpuro MycERt vector was demonstrated after addition of 100 nM of 4OH-tamoxifen by quantitative nuclear fluorescent immunostaining. Nontreated cells used for comparison and cultivated in parallel were treated with ethanol. The nuclear staining of both WT Myc-ERt and D106-MycERt protein increased between two-to four-fold over a 2-4 h period (Figure 1) . Only experiments that showed at least a 50% increase in relative fluorescent intensity of nuclear c-Myc protein levels were utilized for further analysis. As a rule, the relative nuclear fluorescent intensity values for c-Myc protein decreased after 4 h and finally reached relative fluorescent intensity values similar to those of untreated cells after 6 h. In the absence of 4-Hydroxytamoxifen (4HT) or for parental Ba/F3, cells showed only cell cycle dependent fluctuations in their c-Myc protein expression (data not shown).
Both WT and deleted D106 c-myc allele in Ba/F3 induce nonrandom structural and numerical chromosomal alterations
After confirmation of Myc activation, we proceeded to the analysis of chromosomal alterations using spectral karyotyping (SKY) of the identical Ba/F3 cells. The SKY-hybridization protocol was applied on chromosome spreads prepared from parental Ba/F3 cells and from Ba/F3 cells carrying either the WT Myc-ERt or the deleted D106-MycERt allele. The chromosomes were prepared at 0, 24, 48, 72 h and 10 days after 4HT stimulation. A total of 20 metaphases per time point and cell line and with an optimal hybridization signals were analysed in three independent experiments. The differential cytogenetic changes were comparatively analysed (Materials and methods) and their P-values determined. Genomic instability and tumorigenesis are separable events T Fest et al In conclusion, both WT and D106-Myc proteins displayed high levels of significant Myc-associated karyotypic instability and can be summarized as follows (Table 1) Table 1 ). (3) Unique significant alterations for WT Myc that are not found in D106 include chromosomes 10 and 13 (highlighted in red in Table 1 ). (4) Unique significant alterations for D106 include chromosomes 2, 4, 9 and 16 (highlighted in green in Table 1 ).
D106-Myc-induced genetic instability alone is not sufficient to promote tumorigenesis
Since both WT and D106 c-myc alleles induced significant genomic instability, we asked the question whether these abnormalities were sufficient to promote tumorigenesis in SCID mice. Both D106-and WT-Myc carrying Ba/F3 cell lines were treated with 4HT for 48 h. Myc protein activation was verified by immunohistochemistry (IHC) (Materials and methods). 10 6 cells were injected and animals were observed for 3 weeks. Nine out of 26 mice (34.6%) with WT Myc expressing Ba/F3 cells developed tumors within this period. The tumors preferentially formed in the spleen ( Table 2 ) that was enlarged and showed a weight of up to 1 g (as opposed to the normal range of about 80 mg). Metastasis to the liver as well as bone marrow was noted indicating that mice had developed an equivalent of leukemia. Tumor cells presented typical lymphoblastic cell morphology (Figure 4b ), and they immunostained with the B cell marker B220 (Figure 4d ).
Spleen-derived tumor cells from female SCID mice were taken and subsequently analysed by SKY to confirm the Ba/F3 cell origin of the tumors. The (Table 2) .
Similar results on the failure of myc box II deletion and mutant proteins to confer growth in soft agar had been reported for fibroblasts (Conzen et al., 2000) . Thus, our study in pro-B-lymphocytes and an in vivo tumorigenesis model consisting of SCID mice strength- 
. A summary of all significant data is given in Table 1 . Each panel of Figure 2 shows the following order of images, the raw spectral image of the metaphase is shown in the top left corner, the classified image of the identical metaphase is shown in the top middle panel, the inverted DAPI image of the identical metaphase in the top right corner, and the classified karyotype of the identical metaphase is shown in the bottom panel. SKY was carried out for three independent experiments as described in Materials and methods. A minimum of 20 metaphases was analysed per time point and induction scheme Genomic instability and tumorigenesis are separable events T Fest et al ens previous data on the inability of D106 to confer anchorage independent growth and tumor development. Moreover, since our study was performed in a lymphocyte cell line, this behaviour of D106 is independent of cell lineage. In addition, it becomes obvious that genomic instability alone is not sufficient to drive tumorigenesis. Rather, specific genomic instability, as observed here for Ba/F3 cells with activated WT MycERt (Table 1) , is required to promote in vivo tumorigenesis.
Chromosome 10 or 13 rearrangements are retained in WT-MycERt -driven SCID tumors
To determine the relevance of the unique significant aberrations of chromosomes 10 and 13 for WT Mycinduced tumor development following injection of Ba/F3 cells into SCID mice, we used SKY to examine the nine SCID tumors. As shown in a representative image ( Figure 6 ) and in Table 3 , 7/9 SCID tumors retained aberrations of chromosome 10, one retained , þ 4HT) . The summary of all data is given in Table 1 . Each panel of Figure 3 is organized as described in Figure 2 . SKY was carried out as described in Materials and methods. A minimum of 20 metaphases was analysed per time point and induction scheme. Three independent experiments were carried out Genomic instability and tumorigenesis are separable events T Fest et al aberrations of chromosome 13 and 1/9 did not show any aberrations of chromosomes 10 or 13. Interestingly, either chromosomes 10 or 13 aberrations were maintained (with the exception of one mouse), but never both. The aberrations for both chromosomes included insertions, deletions or fusions. Thus, changes of either chromosome 10 or 13 are linked to the promotion of tumor development. Aberrations affecting chromosome 10 were more frequent than those affecting chromosome 13 (Table 3 ; Figure 6 , see arrow). In addition to genetic alterations of these two chromosomes, additional aberrations were noted in the SCID tumors. These included a significant increase of aneuploidy, and other chromosomal aberrations of which chromosome 2 aberrations (in 7/9 tumors) were the most frequent. Examples for unique aberrations that were not shared between individual tumors were changes affecting chromosomes 7 and 15 (Table 3 ).
Discussion
Previous work had shown in Ba/F3 cells that WT and mutant Myc proteins (B13, B16 and D106) induce genomic instability (Fest et al., 2002) . Both WT and Myc mutant proteins induced the locus-specific amplification of dihydrofolate reductase (DHFR). In contrast to WT Myc protein, Myc mutants have the tendency of inducing polyploidization in the absence of apoptosis (Fest et al., 2002) .
In this study we further examined genomic instability induced by WT and mutant Myc proteins in a lymphocyte model of pro-B mouse lympohocytes, Ba/ F3. We focused on myc box II deleted (D106) Myc protein and investigated whether the conditional expression of WT or D106 Myc proteins induced different types of structural and numerical chromosomal aberrations. Furthermore, we investigated whether the type of structural aberrations induced in vitro were relevant for in vivo tumorigenesis as assessed in SCID mice.
Conditional D106 Myc protein expression led to a higher level of structural chromosomal aberrations than conditional WT Myc protein expression (Table 1, Figures 2 and 3 ). This may be linked to the lower levels of apoptosis induced by this deletion mutant (Fest et al., 2002) .
In vivo tumorigenesis studies using D106-activated Ba/F3 cells in comparison to those with deregulated WT Myc showed that only WT Myc protein deregulated Ba/F3 cells were able to generate tumors in SCID mice within a 3-week-time frame (Table 2) . Similar results on a failure of D106 Myc protein to induce growth in soft agar were obtained by others using fibroblasts (Conzen et al., 2000) . Since lymphoid and nonlymphoid cells showed this inability for D106, a cell lineage-specific factor can most likely be excluded. Therefore, all previously tested cell culture models suggest that the deletion or myc box II mutants do no exhibit oncogenic potential in either soft agar or in vivo tumorigenesis as shown in this study.
We conclude that the genetic aberrations identified in conditional D106-deregulated Ba/F3 cells are not sufficient to initiate in vivo tumorigenesis in the SCID mouse model. Despite the fact that conditional D106 Myc protein induces a lower level of apoptosis than WT Myc (Fest et al., 2002) and accumulates more chromosomal changes as shown in the present study, tumorigenesis is not induced within the time frame that allows for tumor development with WT Myc protein. It thus appears that the additional genetic changes induced by D106 are uncoupled from tumor initiation and/or promotion.
Therefore, genomic instability and tumorigenesis are two separable events in conditional D106 Myc protein expressing Ba/F3 cells. The unique significant alterations of chromosomes 2, 4, 9 and 16 that were found in Ba/F3 cells conditionally expressing D106 appear not to contribute to the process of tumor initiation. They may, however, contribute to the suppression of apoptosis.
In contrast, WT MycERt deregulated Ba/F3 cells with lower levels of genetic lesions are fully capable of in vivo tumorigenesis. This suggests that the combination of specific genetic alterations, including the unique significant alterations of chromosomes 10 and 13, are linked to tumor initiation, promotion and metastasis in SCID mice (Tables 2 and 3) .
Taken together, our study leaves us with the paradox that BL patients show recurrent codon specific muta- One may speculate that only a WT Myc protein has the potential of initiating and promoting tumorigenesis of the B lineage cells in BL. If so, mutant Myc proteins might be generated as a secondary event, namely as a result of somatic hypermutation (Pasqualucci et al., 2001; Gaidano et al., 2003) after the oncogenic lesions were already initiated by a WT c-Myc. Mutant Myc proteins would then lower the apoptotic levels of already oncogenic cells and not actively initiate tumorigenesis. Myc mutation could be considered an adaptive process of tumor biology (Raffeld et al., 1995) . In this scenario, the mutant Myc proteins would be unable to induce tumorigenesis because their effects were secondary to oncogenic lesions already induced by a WT Myc protein. Future studies will elucidate these issues.
Materials and methods
Cell lines
The three BaF3 cell lines, parental (NT), WT-MycERt (WT) and D106-MycERt (D106) used in this study have been previously described (Fest et al., 2002) . Cells were grown in RPMI 1640 (Invitrogen, Burlington ON, Canada), containing 10% fetal bovine serum (Gibco, Burlington ON, Canada), 1% WEHI supernatant (IL3) and 0.021% of plasmocin (Cayla, Toulouse, France). Cells were grown and maintained at a density of 10 5 -10 6 cells/ml. Cell viability was determined by hemacytometer counts using trypan blue (Sigma-Aldrich, Oakville ON, Canada).
All three cell lines, NT, WT and D106 were induced with 4HT (Sigma-Aldrich, Oakville ON, Canada) to a final concentration of 100 nM in 10 5 cells/ml to activate the c-Myc Chromosomes 10 and 13 remained with significant aberrations in the SCID tumors. Additional common and less frequent aberrations are as listed.
There is a significant increase of aneuploidy (for details, see text). For a representative image, see Figure 6 Genomic instability and tumorigenesis are separable events T Fest et al protein.
Cells were split 24 h prior induction and every 48 h after 4HT induction. For IHC, we used cytospins from the 0-, 1-, 2-, 4-and 6-h time points, and chromosomes were harvested at 0-, 24-, 48-, 72-h and 10 days time points. Slides for IHC were stored at 41C until use. Both IHC and chromosome preparations were prepared from the same culture dish.
Immunohistochemistry IHC was performed as described previously (Fukasawa et al. 1997) . Cytospins were made the 0-, 1-, 2-, 4-and 6-h time points, and to test for 4HT-mediated activation of MycERt. 4HT activation leads to the nuclear translocation of the otherwise cytoplasmic MycERt (Littlewood et al., 1995) . The primary antibody used was a rabbit polyclonal anti-c-Myc (N262) at a dilution of 1 : 40 (Santa Cruz, California, USA) visualized by using a secondary goat anti-rabbit IgG FITC antibody at a dilution of 1 : 50 (Sigma-Aldrich, Oakville ON, Canada). IHC was also completed on control and tumor tissue samples using paraffin embedded tissue sections from the spleens of the CBySmn.CB17-Prkdc scid /J (SCID) mice used in our study. B cells were detected with a monoclonal anti-B220 FITC antibody at a dilution of 1 : 100 (BD Biosciences, Mississauga, ON, Canada). Analysis of all samples was performed using a Carl Zeiss Axiophot 2 microscope and a Â 63 oil objective. Images were acquired using a Hamamatsu CCD SensiCam Camera and the Northern Eclipse v 6.0 software. Microsoft Excel software was used for calculations and graphs.
SKY analysis
SKY was performed by using the ASI (Applied Spectral Imaging, Vista, CA, USA) kit for mouse and the supplier's hybridization protocols. We used the Spectra Cubet on a Carl Zeiss Axioplan 2 microscope using a Â 63 oil objective and the SKYVIEW 1.6.2 and 2.0 software for PC to carry out analyses. Three independent SKY experiments were performed for each of the NT, WT and D106 cell lines. We also performed SKY on chromosomes collected from the tumors that developed in the SCID mice. Results were charted in Microsoft Excel in order to tabulate and analyse statistically cytogenetic changes detected through SKY.
Statistical analysis
Mean total chromosomes, as well as number of each specific chromosome observed for 4HT treated and nontreated cells were compared over time by two-way analysis of variance. For other chromosomal aberrations such as fusions, translocations and deletions, common (at least 10%) incidences in specific chromosomes were also compared for treated and nontreated cells over time with the Mantel-Haenzsel stratified analysis for those rates. Significance level was set at a ¼ 0.05. The significant univariate findings were combined to discriminate between treated and nontreated cells over time, as well as between different cell lines in a multivariate model. For the SKY results from the nine tumors found in the SCID mice statistical analysis was as follows: A binomial exact test was done to determine if the diploid chromosome copy numbers were as expected 90% or more. A poisson exact test to see if the chromosomal rearrangements were much more than expected rare or equal to 0%. A w 2 exact test was done to determine the significance of deletion rates between the chromosomes. To determine similarities in the chromosomal rearrangements between the mice, a w 2 exact test was done. As there were so many tests done, a bonferroni was applied.
In vivo tumorigenesis assays using SCID mice Dose-assay tests were first conducted for tumorigenicity with three doses of Ba/F3 cells (10 3 , 10 5 and 10 7 cells/mouse; two mice/cell concentration). 10 3 and 10 5 cells/mouse did not promote tumor formation within 4 weeks, while 10 7 cells led to tumor development within a short period of about 2 weeks. We therefore chose a concentration of 10 6 cells/mouse for our study. Using this number of Ba/F3 cells, tumors were observed within a 3-week period. Prior to injection, the Ba/F3 WT and D106 cells were treated with 4HT, and IHC was done on cytospins from the same culture to confirm Myc activation. At 48 h after 4HT treatment, cells presenting 95% of viability by trypan blue were injected into 6-week-old CBySmn.CB17-Prkdc scid /J mice (SCID mice) (Jackson laboratories) (Internal Protocol Number 98-059/1/2/3) using the intraperitoneal (i.p.) injection method. In total, 20 (10 female and 10 male) 6-weekold SCID mice were included in the experiment for D106 cells and 26 (16 female and 10 male) for Ba/F3 WT cells. The mice were observed for 3 weeks. At that time, the mice were killed and an autopsy was carried out to confirm the presence of tumors. Tumors of mice that had been injected with Ba/F3 cells typically led to an enlarged spleen, which was also associated with liver and/or bone marrow involvement.
Hematoxylin/eosin (H&E) staining
We paraffin embedded spleen samples from both the tumorcarrying and nontumor-carrying SCID mice and used the H&E staining technique (Kumagai et al., 2003) to visualize the tumor and normal tissue samples. The images were taken using a Carl Zeiss Axioskop 2 microscope using a Â 63 oil objective and a Polaroid 24-bit colour camera DMC and the DMC v 1.0 software.
